Eir Ventures Closes Life Science Venture Fund at EUR122 million
STOCKHOLM and COPENHAGEN, Denmark, Dec. 9, 2021 /PRNewswire/ -- Eir Ventures Partners AB ("Eir Ventures" or "the Fund"), a Nordic Life Science Venture Capital manager, today announced the final close of its fund Eir Ventures I AB of EUR 122.3 million.
- STOCKHOLM and COPENHAGEN, Denmark, Dec. 9, 2021 /PRNewswire/ -- Eir Ventures Partners AB ("Eir Ventures" or "the Fund"), a Nordic Life Science Venture Capital manager, today announced the final close of its fund Eir Ventures I AB of EUR 122.3 million.
- The fund invests in innovative life science companies with products and technologies addressing significant unmet medical needs.
- Dr Magnus PerssonMD PhD, Founding Partner and Chairman of Eir Ventures, added,"We thank our loyal and new investors for their trust in Eir Ventures.
- Eir Ventures is a life science focused venture fund, that with a strong foundation in the Nordic Biotech ecosystem invests in early stage as well as more mature opportunities.